Retraction

Clinical investigation: increased serum stromal derived factor 1 alpha levels in pulmonary tuberculosis

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

3/28/2017

Citations (3)

3
Total Citations
1
Post-Retraction
(33.3%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
0 After 2+ years
422 Days since retraction (latest)
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis
Jeong Sup Song, Chun Mi Kang, Hyeon Hui Kang et al. (8 authors)
Experimental & Molecular Medicine Open Access
Published: Jan 2010
103 citations
422 days after retraction
Dual Effect of AMD3100, a CXCR4 Antagonist, on Bleomycin-Induced Lung Inflammation
Masaki Watanabe, Wataru Matsuyama, Yuko Shirahama et al. (9 authors)
The Journal of Immunology Open Access
Published: May 2007
19 citations
554 days before retraction
Paper citing Clinical investigation: increased serum stromal de...
Unknown Authors
Unknown Journal
Published: Jan 2007
674 days before retraction
Quick Stats
Total Citations: 3
Years Since Retraction: 17.0 years
Open Access: Yes
Last Checked: Never
Related Papers
Seropositivity and Titers of AntiSmooth Muscle Actin Antibo…
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research • 3 citations
The Charms of the CHRM Receptors: Apoptotic and Amoebicidal…
Antimicrobial Agents and Chemotherapy • 0 citations
CCR5 blockade in combination with rapamycin prolongs cardia…
Clinical and Experimental Immunology • 11 citations